Clinical Trial Update: Vitamin D3 Supplementation in Dialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Vitamin D3 (cholecalciferol) supplementation in patients with End-Stage Renal Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: End-Stage Renal Disease | Phase 2 | Status: COMPLETED